In conclusion, in this study, a significant decrease was detected in the Hb levels measured in the first year following the initial administration of ACEIs or ARBs to patients with hypertension and/or diabetes but without significant renal failure and anemia. This evidence concerns the gene GSTM1 and diabetes mellitus.